1. Resistin promotes the abnormal Type I collagen phenotype of subchondral bone in obese patients with end stage hip osteoarthritis
   Ashleigh M. Philp et al, 2017, Scientific Reports CrossRef
2. Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway
   Rui‑Xiong Huang et al, 2020, Molecular Medicine Reports CrossRef
3. Diet-derived fruit and vegetable metabolites show sex-specific inverse relationships to osteoporosis status
   Kelsey M. Mangano et al, 2021, Bone CrossRef
4. The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis
   Gabriela Mihai et al, 2019, Aging Clinical and Experimental Research CrossRef
5. At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives
   Shanmugam Muruganandan et al, 2020, International Journal of Molecular Sciences CrossRef
6. Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review
   Fnu Deepika et al, 2023, Biomedicines CrossRef
7. Beyond mechanical loading: The metabolic contribution of obesity in osteoarthritis unveils novel therapeutic targets
   Basma H. Sobieh et al, 2023, Heliyon CrossRef
8. Adipokines as targets in musculoskeletal immune and inflammatory diseases
   María González-Rodríguez et al, 2022, Drug Discovery Today CrossRef
9. Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study
   Hana Hulejová et al, 2019, Rheumatology International CrossRef
10. Interplay between fat cells and immune cells in bone: Impact on malignant progression and therapeutic response
    Alexis Wilson et al, 2022, Pharmacology & Therapeutics CrossRef
11. Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis
    Eloi Franco-Trepat et al, 2019, Journal of Clinical Medicine CrossRef
12. The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
    Simone Torretta et al, 2020, Cells CrossRef
13. NAMPT expression in osteoblasts controls osteoclast recruitment in alveolar bone remodeling
    Bassam Hassan et al, 2018, Journal of Cellular Physiology CrossRef
14. NAMPT: A pleiotropic modulator of monocytes and macrophages
    Cristina Travelli et al, 2018, Pharmacological Research CrossRef
15. Integrated Analysis of Crucial Genes and miRNAs Associated with Osteoporotic Fracture of Type 2 Diabetes
    Liang Mo et al, 2022, BioMed Research International CrossRef
16. Tetrandrine attenuates the bone erosion in collagen‐induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase
    Yugai Jia et al, 2018, The FASEB Journal CrossRef
17. Visfatin and Rheumatoid Arthritis: Pathogenetic Implications and Clinical Utility
    Yulia V. Polyakova et al, 2020, Current Rheumatology Reviews CrossRef
18. Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females
    Sundus Tariq et al, 2022, Frontiers in Endocrinology CrossRef